Table 3a.
CTCAE grade ≥3 events reported by any patient
Patients with grade ≥3 event, N (%) | |||||
---|---|---|---|---|---|
AZD4877 dose | |||||
10 mg (N = 3) | 15 mg (N = 3) | 20 mg (N = 6) | 25 mg (N = 6) | Total (N = 18) | |
Any grade ≥3 event | 0 | 0 | 1 (17) | 2 (33) | 3 (17) |
Febrile neutropenia | 0 | 0 | 0 | 1 (17) | 1 (6) |
Neutropenia | 0 | 0 | 1 (17) | 0 | 1 (6) |
Constipation | 0 | 0 | 0 | 1 (17) | 1 (6) |
Fatigue | 0 | 0 | 0 | 1 (17) | 1 (6) |
Urinary tract infection | 0 | 0 | 0 | 1 (17) | 1 (6) |
Anorexia | 0 | 0 | 0 | 1 (17) | 1 (6) |